PANDOLFI, Assunta
 Distribuzione geografica
Continente #
NA - Nord America 6.937
EU - Europa 5.271
AS - Asia 4.641
SA - Sud America 510
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 11
AN - Antartide 1
Totale 17.461
Nazione #
US - Stati Uniti d'America 6.790
SG - Singapore 1.854
CN - Cina 1.512
IT - Italia 1.287
IE - Irlanda 756
UA - Ucraina 661
SE - Svezia 583
TR - Turchia 532
GB - Regno Unito 475
FR - Francia 467
BR - Brasile 416
DE - Germania 370
IN - India 258
VN - Vietnam 214
FI - Finlandia 189
RU - Federazione Russa 138
CA - Canada 78
AT - Austria 77
NL - Olanda 60
PL - Polonia 60
MX - Messico 50
HK - Hong Kong 49
CZ - Repubblica Ceca 43
AR - Argentina 38
KR - Corea 36
JP - Giappone 35
BD - Bangladesh 27
ZA - Sudafrica 26
ES - Italia 24
TW - Taiwan 24
BE - Belgio 23
EC - Ecuador 18
EU - Europa 17
IR - Iran 17
EG - Egitto 14
LT - Lituania 13
ID - Indonesia 12
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
RO - Romania 9
PK - Pakistan 8
SA - Arabia Saudita 8
AU - Australia 7
CL - Cile 7
PY - Paraguay 7
VE - Venezuela 7
CR - Costa Rica 6
ET - Etiopia 6
GR - Grecia 6
IQ - Iraq 6
PE - Perù 6
CH - Svizzera 5
IL - Israele 5
LB - Libano 5
MA - Marocco 5
NO - Norvegia 5
UZ - Uzbekistan 5
BO - Bolivia 4
CO - Colombia 4
NP - Nepal 4
PA - Panama 4
XK - ???statistics.table.value.countryCode.XK??? 4
BG - Bulgaria 3
JO - Giordania 3
MT - Malta 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 3
SN - Senegal 3
TN - Tunisia 3
AZ - Azerbaigian 2
EE - Estonia 2
GD - Grenada 2
KZ - Kazakistan 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
OM - Oman 2
TT - Trinidad e Tobago 2
AL - Albania 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BZ - Belize 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
KW - Kuwait 1
LY - Libia 1
MK - Macedonia 1
PW - Palau 1
Totale 17.456
Città #
Singapore 1.285
Chandler 874
Jacksonville 757
Dublin 750
Beijing 410
Ashburn 368
Dallas 359
Houston 331
Princeton 319
Southend 302
Dearborn 292
Chieti 273
Izmir 254
Nanjing 240
The Dalles 201
Los Angeles 190
Wilmington 178
Pescara 166
Santa Clara 151
Ann Arbor 140
Cambridge 126
New York 123
Altamura 108
Boardman 108
Munich 106
Nanchang 94
Tongling 93
Woodbridge 77
Buffalo 69
Rome 64
Ho Chi Minh City 62
Vienna 62
São Paulo 54
Redondo Beach 51
Dong Ket 45
Hefei 45
Denver 44
Shenyang 43
Hanoi 41
Hebei 41
Kunming 41
Brooklyn 40
Helsinki 38
Washington 38
Brno 36
Jiaxing 36
Milan 36
Tianjin 35
Amsterdam 34
Hong Kong 34
Tokyo 34
Warsaw 34
Ascoli Piceno 28
Nuremberg 28
Augusta 27
Guangzhou 27
Norwalk 27
Council Bluffs 26
Toronto 26
Ningbo 25
Turku 25
Falls Church 24
Grevenbroich 23
Hangzhou 23
Johannesburg 23
San Mateo 23
Changsha 22
Chennai 22
Seattle 22
Brussels 21
London 21
Montreal 21
Seoul 21
Phoenix 19
Stockholm 19
Jinan 18
Atlanta 17
Boston 17
Fairfield 17
Poplar 17
Querétaro 17
Chicago 16
Kocaeli 16
Mexico City 16
Orem 16
Leawood 15
Rio de Janeiro 15
San Francisco 15
Central 13
Shanghai 13
Belo Horizonte 12
Charlotte 12
Frankfurt am Main 12
Lanciano 12
Mumbai 12
Zhengzhou 12
Cairo 11
Kraków 11
Orange 11
Bialystok 10
Totale 10.628
Nome #
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia] 426
NEW DRUG DELIVERY SYSTEM FOR OPHTALMIC USE 189
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 186
Molecular and phenotypic characterization of human amniotic fluid-derived cells: A morphological and proteomic approach 174
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 171
Osteogenic differentiation of amniotic fluid mesenchymal stromal cells and their bone regeneration potential 171
Ovotioli per il trattamento della Infiammazione Sistemica Cronica di Basso Grado (ISC) e delle patologie ad essa correlate 170
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 168
Wnt Signaling Behaves as a "Master Regulator" in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem Cells 167
Establishment and long-term culture of human cystic fibrosis endothelial cells 167
Plasma protein carbonylation in chronic uremia 160
Mechanisms of endothelial cell dysfunction in cystic fibrosis 159
Anti-inflammatory Role of Carotenoids in Endothelial Cells Derived from Umbilical Cord of Women Affected by Gestational Diabetes Mellitus 158
Plasma from pre-pubertal obese children impairs insulin stimulated Nitric Oxide (NO) bioavailability in endothelial cells: Role of ER stress 153
Anti-Inflammatory Activity of Marine Ovothiol A in an In Vitro Model of Endothelial Dysfunction Induced by Hyperglycemia 148
Calcitonin-induced effects on amniotic fluid-derived mesenchymal stem cells 146
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 145
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells 145
Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation 145
Centella Asiatica inhibits TNFα-induced adhesion molecule expression in endothelial cells of umbilical cords from gestational diabetic women. 144
Calcimimetic R-568 vasodilatory effect effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs) 143
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 142
ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1678-83. 139
Insulin enhances vascular adhesion molecule (VCAM-1) expression in human cultured endothelial cells through a pro-atherogenic p38MAP-kinase mediated pathway. 137
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 137
Relationship between patient-practice oriented knowledge and metabolic control in intensively treated Type 1 diabetic patient: Result of the validation of the knowledge and Practices Diabetes Questionnaire 136
Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice. 136
Chondrogenic Differentiation of Human Wharton’s Jelly and Bone Marrow-Derived Mesenchymal Stem Cells: Focus on the Role of an Acrylamide-Free Cross-Linked Hyaluronic Acid Hydrogel 136
Human Mesenchymal Stem Cells Reendothelialize Porcine Heart Valve Scaffolds: Novel Perspectives in Heart Valve Tissue Engineering 134
Mesenchymal stromal cells from amniotic fluid are less prone to senescence compared to those obtained from bone marrow: An in vitro study 134
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 133
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 133
Osteogenic transdifferentiation of vascular smooth muscle cells isolated from spontaneously hypertensive rats and potential menaquinone-4 inhibiting effect 132
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells 131
Ovothiols for the treatment of chronic low-grade systemic inflammation (CLGSI) and related diseases. 130
Menaquinone-4 enhances osteogenic potential of human Amniotic Fluid Mesenchymal Stem Cells Cultured in a 2D and 3D dynamic culture systems 129
Acute hyperglycemia and acute hyperinsulinemia both decrease plasma fibrinolytic activity and increase plasminogen activator type-1 (PAI-1) in the rat. 128
Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation. 128
Association of the 1q25 Diabetes-Specific Coronary Heart Disease Locus With Alterations of the γ-Glutamyl Cycle and Increased Methylglyoxal Levels in Endothelial Cells 128
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 127
TRAIL modula l’attivita’ della ossido nitrico sintasi endoteliale (eNOS): possibile ruolo di tale citochina nella localizzazione intracellulare di eNOS in colture di cellule endoteliali primarie 127
Centella Asiatica and Lipoic Acid, or a combination thereof, inhibit monocyte adhesion to endothelial cells from umbilical cords of gestational diabetic women 125
Features of endothelial dysfunction in umbilical cord vessels of women with gestational diabetes 125
Tumor necrosis factor-alpha and mast cells: Revisited study 123
Arterial wall and liver of diabetic rats exhibit increased synthesis of plasminogen activator inhibitor-1 (PAI-1). 122
TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells. 122
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 122
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro. 120
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. 120
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 120
The use of ovothiols for inflammatory diseases also diseases-related is disclosed (Cina) 120
Age-dependent changes in the expression of superoxide dismutases and catalase are associated with ultrastructural modifications in human granulosa cells 120
Transcriptome analysis of human primary endothelial cells (HUVEC) from umbilical cords of Gestational Diabetic mothers reveals candidate sites for an epigenetic modulation of specific gene expression. 119
TRAIL/Apo2L stimola la produzione di ossido nitrico e di prostanoidi in colture di cellule endoteliali primarie 118
L-Carnitine is an osmotic agent suitable for peritoneal dialysis 118
Cytotoxic and genotoxic effects of composite resins on cultured human gingival fibroblasts 118
Association Between a Genetic Variant Related to Glutamic Acid Metabolism and Coronary Heart Disease in Individuals With Type 2 Diabetes 117
Chronic in vivo hyperglycaemia increases nitroxidant stress and hinders nitric oxide availability in human vessels and human endothelial cells 117
An Italian Innovative Small-Scale Approach to Promote the Conscious Consumption of Healthy Food 117
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients 116
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 114
Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter 113
Identification and Characterization of a Stem Cell-Like Population in Bovine Milk: A Potential New Source for Regenerative Medicine in Veterinary 113
Metabolic Syndrome in Survivors from the 2009 Earthquake in Italy 112
Plasminogen Activator Inhibitor-1 synthesis is increased in arterial wall of diabetic subjects 111
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 111
High glucose, nitric oxide, and adenosine: a vicious circle in chronic hyperglycaemia? 111
Increased iNOS activity in vascular smooth muscle cells from diabetic rats: Potential role of Ca2+/calmodulin-dependent protein kinase II delta 2 (CaMKIIδ2) 111
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture. 110
A high-score Mediterranean dietary pattern is associated with a reduced risk of peripheral arterial disease in Italian patients with Type 2 diabetes 110
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 110
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 109
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity. 109
Bioengineered Human Stromal Lenticule for Recombinant Human Nerve Growth Factor Release: A Potential Biocompatible Ocular Drug Delivery System 109
Iperespressione dell'inibitore dell'attivatore del plasminogeno di tipo 1 (PAI-1) nel fegato e nella aorta di ratti diabetici 108
Induction of prostacyclin by steady laminar shear stress suppresses Tumor Necrosis Factor-alfa biosyntesis via Heme Oxygenase-1 in human endothelial cells. 108
Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular Lenses 107
Serum and glucocorticoid-inducible kinase 1 (SGK1) regulates adipocyte differentiation via Forkhead box O1. 107
C-reactive protein: a potential new molecular link between imflammation, thrombosis and vascular cell proliferation? 106
Selective insulin resistance affecting nitric oxide release but nor plasminogen activator inhibitor-1 synthesis in fibroblast from insulin-resistant individuals. 106
Liraglutide mitigates TNF-alfa induced pro-atherogenic changes and microvesicle release in HUVEC from diabetic women 106
Plasminogen activator inhibitor type 1 is increased in the arterial wall of type 2 diabetic subjects 104
TRAIL/Apo2L sequentially up-regulates nitric oxide and prostanoid production in primary endothelial cells 103
The TRIB3 R84 variant is associated with increased carotid intima-media thickness in vivo and with enhanced MAPK signalling in human endothelial cells. 103
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance. 103
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 101
I livelli di inibitore dell’attivatore del plasminogeno-1 (PAI-1) risultano aumentati nella parete arteriosa di pazienti diabetici 101
β-Carotene and lycopene affect endothelial response to TNF-α reducing nitro-oxidative stress and interaction with monocytes. 101
Endothelial cells from umbilical cord of women affected by gestational diabetes: A suitable in vitro model to study mechanisms of early vascular senescence in diabetes 101
Both acute and chronic hyperglycemia decrease plasma fribrinolytic activity in the rat. 100
The use of ovothiols for inflammatory diseases also disease-related is disclosed (Europe) 100
Myoinositol reduces inflammation and oxidative stress in human endothelial cells exposed in vivo to chronic hyperglycemia 100
Synergic effect of glucose and insulin in stimulating plasminogen activator inhibitor 1 (PAI-1) expression and secretion in human vascular smooth cells (vSMC) 99
Surfactant protein A-Producing Cells in Human Fetal Lung are good Targets for recombinant Adenovirus-Mediated Gene Transfer. 99
Acute hyperinsulinemia decreases plasma fibrinolytic activity in the rat 99
Circulating Extracellular Vesicles Are Increased in Newly Diagnosed Celiac Disease Patients 98
Increased plasma levels of Platelet-Derived Growth Factor activity in patients with Progressive Systemic Sclerosis. 98
Vascular inflammation in end-stage renal disease: the red blood cell connection 98
The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. 97
Calcimimetic R-568 and its enantiomer induce a rapid, reversible, and only partially endothelium-mediated vasodilation in perfused mesenteric arteries from normotensive and spontaneously hypertensive rats 97
Totale 12.774
Categoria #
all - tutte 75.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.429


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021722 0 0 0 0 0 215 31 50 111 128 102 85
2021/2022923 35 20 19 191 65 36 35 56 75 32 106 253
2022/20232.505 202 325 138 280 229 478 141 216 323 30 96 47
2023/20241.384 88 48 102 74 73 411 280 42 17 36 10 203
2024/20253.676 182 565 477 190 81 118 225 247 429 138 445 579
2025/20263.282 604 292 699 884 742 61 0 0 0 0 0 0
Totale 18.544